+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Chronic Lower Back Pain Market Opportunities and Strategies to 2034

  • PDF Icon

    Report

  • 316 Pages
  • March 2025
  • Region: Global
  • The Business Research Company
  • ID: 6059247
This report describes and explains the chronic lower back pain market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global chronic lower back pain market reached a value of nearly $7.72 billion in 2024, having grown at a compound annual growth rate (CAGR) of 2.60% since 2019. The market is expected to grow from $7.72 billion in 2024 to $9.7 billion in 2029 at a rate of 4.67%. The market is then expected to grow at a CAGR of 4.36% from 2029 and reach $12.01 billion in 2034.

Growth in the historic period resulted from the favorable government initiatives, growing awareness about pain management and strong economic growth in emerging markets. Factors that negatively affected growth in the historic period were low health access in developing countries.

Going forward, increasing healthcare expenditure, rising aging population, rising prevalence of chronic diseases and increasing healthcare access in emerging markets will drive the growth. Factor that could hinder the growth of the chronic lower back pain market in the future include limited availability of skilled professionals.

The global chronic lower back pain market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 42.25% of the total market in 2023. Johnson & Johnson Services Inc. was the largest competitor with a 8.08% share of the market, followed by Pfizer Inc. with 5.81%, Novartis AG. with 5.62%, Medtronic plc. with 5.32%, Eli Lilly and Company. With 5.27%, Hisamitsu Pharmaceutical Co. Inc. with 2.60%, Boehringer Ingelheim GmbH. with 2.55%, AstraZeneca plc. with 2.47%, Endo International plc with 2.27% and AbbVie Inc. with 2.24%.

North America was the largest region in the chronic lower back pain market, accounting for 40.57% or $3.13 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the chronic lower back pain market will be Asia Pacific and South America where growth will be at CAGRs of 5.71% and 5.40% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 4.98% and 4.81% respectively.

The chronic lower back pain market is segmented by type of pain into diskogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, muscular pain and other types of pain. The diskogenic pain market was the largest segment of the chronic lower back pain market segmented by type of pain, accounting for 32.56% or $2.51 billion of the total in 2024. Going forward, the radicular pain segment is expected to be the fastest growing segment in the chronic lower back pain market segmented by type of pain, at a CAGR of 5.66% during 2024-2029.

The chronic lower back pain market is segmented by diagnosis into clinical history, physical examination, imaging guidelines and assessment of pain. The clinical history market was the largest segment of the chronic lower back pain market segmented by diagnosis, accounting for 33.68% or $2.6 billion of the total in 2024. Going forward, the imaging guidelines segment is expected to be the fastest growing segment in the chronic lower back pain market segmented by diagnosis, at a CAGR of 6.89% during 2024-2029.

The chronic lower back pain market is segmented by end-user into hospitals, orthopedic clinics, ambulatory surgery centers and other end-users. The hospitals market was the largest segment of the chronic lower back pain market segmented by end-user, accounting for 44.65% or $3.44 billion of the total in 2024. Going forward, the ambulatory surgery centers segment is expected to be the fastest growing segment in the payments market segmented by end-user, at a CAGR of 6.54% during 2024-2029.

The top opportunities in the chronic lower back pain market segmented by type of pain will arise in the diskogenic pain segment, which will gain $676.24 million of global annual sales by 2029. The top opportunities in the chronic lower back pain market segmented by diagnosis will arise in the imaging guidelines segment, which will gain $869.6 million of global annual sales by 2029. The top opportunities in the chronic lower back pain market segmented by end-user will arise in the hospitals segment, which will gain $788.5 million of global annual sales by 2029. The chronic lower back pain market size will gain the most in USA at $625.79 million.

Market-trend-based strategies for the chronic lower back pain market include innovative spinal cord stimulation approved for non-surgical back and leg pain, artificial intelligence (AI)- infused spinal cord stimulation, developing products with advanced technologies such as BurstDR SCS technology, personalized back pain solutions powered by artificial intelligence (AI) and medical insights, development of advanced treatment facilities to provide comprehensive care for managing pain stemming and cutting-edge TGF-β modulation therapy.

Player-adopted strategies in the chronic lower back pain market include focus on strengthening their business expertise through new drug launches, focus on expanding its business operations through partnerships and renewals and focus on expanding its business through new product approvals.  

To take advantage of the opportunities, the analyst recommends the chronic lower back pain companies to focus on advancing non-surgical pain management solutions, focus on Ai-infused spinal cord stimulation, focus on developing advanced pain management technologies, focus on personalized Ai-powered solutions, focus on expanding advanced treatment facilities, focus on radicular pain to drive growth, expand in emerging markets, continue to focus on developed markets, focus on expanding strategic distribution partnerships, focus on value-based pricing for chronic lower back pain solutions, focus on targeted digital campaigns, focus on partnerships with healthcare providers and focus on targeted strategies for orthopedic clinics.

Major Market Trends

  • Innovative Spinal Cord Stimulation Approved For Non-Surgical Back and Leg Pain
  • AI-Infused Spinal Cord Stimulation Redefines Pain Therapy
  • Revolutionizing Chronic Back Pain Treatment With Spinal Cord Stimulation Technology
  • Personalized Back Pain Solutions Powered by AI and Medical Insights
  • Advanced Treatment Facility For Managing Chronic Pain From Various Causes
  • Cutting-Edge TGF-Β Modulation Therapy Progresses in Clinical Trials

Key Mergers and Acquisitions

  • Boston Scientific Acquired Relievant Medsystems To Expand Chronic Pain Management Portfolio
  • Stryker Corporation Acquired Vertos Medical To Enhance Minimally Invasive Pain Management Portfolio
  • Nevro Corp Acquired Vyrsa Technologies For Expanding Chronic Pain Treatment Solutions
  • Silony Medical International AG Acquired Centinel Fusion Portfolio To Improve Treatment Options

Table of Contents

1 Executive Summary
1.1 Chronic Lower Back Pain - Market Attractiveness and Macro economic Landscape
2 Table of Contents3 List of Tables4 List of Figures5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Chronic Lower Back Pain Market Definition and Segmentations
6.4 Market Segmentation by Type of Pain
6.4.1 Diskogenic Pain
6.4.2 Lumbar Spinal Stenosis
6.4.3 Sacroiliac Pain
6.4.4 Facet-Joint Pain
6.4.5 Radicular Pain
6.4.6 Muscular Pain
6.4.7 Other Types of Pain
6.5 Market Segmentation by Diagnosis
6.5.1 Clinical History
6.5.2 Physical Examination
6.5.3 Imaging Guidelines
6.5.4 Assessment of Pain
6.6 Market Segmentation by End-User
6.6.1 Hospitals
6.6.2 Orthopedic Clinics
6.6.3 Ambulatory Surgery Centers
6.6.4 Other End-Users
7 Major Market Trends
7.1 Innovative Spinal Cord Stimulation Approved For Non-Surgical Back and Leg Pain
7.2 AI-Infused Spinal Cord Stimulation Redefines Pain Therapy
7.3 Revolutionizing Chronic Back Pain Treatment With Spinal Cord Stimulation Technology
7.4 Personalized Back Pain Solutions Powered by AI and Medical Insights
7.5 Advanced Treatment Facility For Managing Chronic Pain From Various Causes
7.6 Cutting-Edge TGF-? Modulation Therapy Progresses in Clinical Trials
8 Chronic Lower Back Pain Market - Macro Economic Scenario
8.1 COVID-19 Impact on the Chronic Lower Back Pain Market
8.2 Impact of the War in Ukraine on the Chronic Lower Back Pain Market
8.3 Impact of High Inflation on the Chronic Lower Back Pain Market
9 Global Market Size Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2019-2024, Value ($ Million)
9.2.1 Market Drivers 2019-2024
9.2.2 Market Restraints 2019-2024
9.3 Forecast Market Growth, 2024-2029, 2034F Value ($ Million)
9.3.1 Market Drivers 2024-2029
9.3.2 Market Restraints 2024-2029
10 Global Chronic Lower Back Pain Market Segmentation
10.1 Global Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
10.2 Global Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
10.3 Global Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
11 Chronic Lower Back Pain Market, Regional and Country Analysis
11.1 Global Chronic Lower Back Pain Market, by Region, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
11.2 Global Chronic Lower Back Pain Market, by Country, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.3 Asia-Pacific Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.4 Asia-Pacific Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.5 Asia-Pacific Chronic Lower Back Pain Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.9 China Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.10 China Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.11 India Market
12.12 India Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.13 India Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.14 India Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.15 Japan Market
12.16 Japan Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.17 Japan Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.18 Japan Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.19 Australia Market
12.20 Australia Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.21 Australia Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.22 Australia Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.25 Indonesia Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.26 Indonesia Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.29 South Korea Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
12.30 South Korea Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate tax structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.3 Western Europe Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.4 Western Europe Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.5 Western Europe Chronic Lower Back Pain Market: Country Analysis
13.6 UK Market
13.7 UK Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.8 UK Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.9 UK Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.10 Germany Market
13.11 Germany Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.12 Germany Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.13 Germany Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.14 France Market
13.15 France Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.16 France Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.17 France Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.18 Italy Market
13.19 Italy Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.20 Italy Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.21 Italy Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.22 Spain Market
13.23 Spain Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.24 Spain Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
13.25 Spain Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Major Companies
14.2 Eastern Europe Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
14.3 Eastern Europe Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
14.4 Eastern Europe Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
14.5 Eastern Europe Chronic Lower Back Pain Market: Country Analysis
14.6 Russia Market
14.7 Russia Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
14.8 Russia Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
14.9 Russia Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.3 North America Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.4 North America Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.5 North America Chronic Lower Back Pain Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.9 USA Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.10 USA Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.11 Canada Market
15.12 Canada Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.13 Canada Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
15.14 Canada Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Major Companies
16.2 South America Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
16.3 South America Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
16.4 South America Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
16.5 Brazil Market
16.6 Brazil Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
16.7 Brazil Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
16.8 Brazil Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
17.3 Middle East Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
17.4 Middle East Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Chronic Lower Back Pain Market, Segmentation by Type of Pain, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
18.3 Africa Chronic Lower Back Pain Market, Segmentation by Diagnosis, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
18.4 Africa Chronic Lower Back Pain Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2029F, 2034F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Johnson & Johnson
19.2.1 Company Overview
19.2.2 Products and Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Pfizer Inc
19.3.1 Company Overview
19.3.2 Products and Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Novartis AG
19.4.1 Company Overview
19.4.2 Products and Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Medtronic Inc
19.5.1 Company Overview
19.5.2 Products and Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Eli Lilly and Company
19.6.1 Company Overview
19.6.2 Products and Services
19.6.3 Financial Overview
20 Other Major and Innovative Companies
20.1 Hisamitsu Pharmaceutical Co. Inc
20.1.1 Company Overview
20.1.2 Products and Services
20.2 Boehringer Ingelheim GmbH
20.2.1 Company Overview
20.2.2 Products and Services
20.3 AstraZeneca plc
20.3.1 Company Overview
20.3.2 Products and Services
20.4 Endo International plc
20.4.1 Company Overview
20.4.2 Products and Services
20.5 AbbVie Inc
20.5.1 Company Overview
20.5.2 Products and Services
20.6 Grünenthal GmbH
20.6.1 Company Overview
20.6.2 Products and Services
20.7 Amgen Inc
20.7.1 Company Overview
20.7.2 Products and Services
20.8 Teva Pharmaceutical Industries Ltd
20.8.1 Company Overview
20.8.2 Products and Services
20.9 Collegium Pharmaceutical Inc
20.9.1 Company Overview
20.9.2 Products and Services
20.10 Merck & Co. Inc
20.10.1 Company Overview
20.10.2 Products and Services
20.11 BioWave Corporation
20.11.1 Company Overview
20.11.2 Products and Services
20.12 Boston Scientific Corporation
20.12.1 Company Overview
20.12.2 Products and Services
20.13 Abbott Laboratories
20.13.1 Company Overview
20.13.2 Products and Services
20.14 Vertebral Technologies Inc
20.14.1 Company Overview
20.14.2 Products and Services
20.15 Neuraxpharm Group
20.15.1 Company Overview
20.15.2 Products and Services
21 Competitive Benchmarking22 Competitive Dashboard
23 Key Mergers and Acquisitions
23.1 Boston Scientific Acquired Relievant Medsystems To Expand Chronic Pain Management Portfolio
23.2 Stryker Corporation Acquired Vertos Medical To Enhance Minimally Invasive Pain Management Portfolio
23.3 Nevro Corp Acquired Vyrsa Technologies For Expanding Chronic Pain Treatment Solutions
23.4 Silony Medical International AG Acquired Centinel Fusion Portfolio To Improve Treatment Options
24 Opportunities and Strategies
24.1 Global Chronic Lower Back Pain Market in 2029 - Countries Offering Most New Opportunities
24.2 Global Chronic Lower Back Pain Market in 2029 - Segments Offering Most New Opportunities
24.3 Global Chronic Lower Back Pain Market in 2029 - Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Chronic Lower Back Pain Market, Conclusions and Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 About the Analyst
26.6 Copyright and Disclaimer

Executive Summary

Chronic Lower Back Pain Global Market Opportunities And Strategies To 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global chronic lower back pain market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description

Where is the largest and fastest-growing market for chronic lower back pain? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The chronic lower back pain market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider chronic lower back pain market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of pain, by diagnosis and by end-user.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the chronic lower back pain market.
  • Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type of pain, by diagnosis and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - This section includes recommendations for chronic lower back pain providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type Of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain
2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment Of Pain
3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users

Key Companies Mentioned: Johnson & Johnson Services Inc.; Pfizer Inc.; Novartis AG; Medtronic plc; Eli Lilly and Company; Hisamitsu Pharmaceutical Co. Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; chronic lower back pain indicators comparison.

Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

The major companies featured in this Chronic Lower Back Pain market report include:
  • Johnson & Johnson Services Inc.
  • Pfizer Inc.
  • Novartis AG
  • Medtronic plc
  • Eli Lilly and Company
  • Hisamitsu Pharmaceutical Co. Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Boehringer Ingelheim GmbH
  • AstraZeneca plc
  • Endo International plc
  • AbbVie Inc.
  • Hoogland Spine Products (HSP) GmbH
  • Huaxiang Group
  • Neurabody
  • NEC Corporation
  • King Edward Memorial (KEM) Hospital
  • Mesoblast Limited
  • Dr. Reddy’s Laboratories Ltd
  • Kyowa Kirin Co., Ltd
  • Argenx
  • Axis Spine Technologies
  • Persica Pharmaceuticals
  • Ipsen Pharma
  • Bayer HealthCare
  • Biotronik
  • Velocity Clinical
  • Menarini Group
  • Almirall
  • Grünenthal
  • Sanofi S.A
  • Endo
  • Koninklijke Philips N.V
  • Abbott Laboratories
  • Trinity Biotech plc
  • EKF Diagnostics
  • A. Menarini Diagnostics Ltd
  • Roche Diagnostics
  • Bio-Rad Laboratories
  • Pain BC
  • DiscGenics
  • Boston Scientific Corporation
  • BioWave Corporation
  • Persica Pharmaceuticals
  • Zimmer Biomet Holdings Inc
  • AppliedVR
  • Relievant Medsystems Inc
  • Nevro Corp
  • Vyrsa Technologies
  • Neuronoff
  • Creative Medical Technology Holdings, Inc
  • NRX Pharmaceuticals Inc
  • Stryker Corporation
  • Vertos Medical Inc
  • Pacira Biosciences Inc
  • Aspen Medical Products
  • SpineGuard
  • EMS S/A
  • ZygoFix
  • Medoc Ltd
  • BrainsWay Ltd
  • Sandoz Group AG
  • Southern Medical (Pty) Ltd
  • SASpine
  • EliteSurgical
  • TiTaMED
  • iSpine
  • GE Healthcare

Table Information